| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 948 | 11.939 | 10.835 | 13.667 | 10.448 | 10.534 |
| Total Income - EUR | - | - | - | - | 1.307 | 16.102 | 14.546 | 17.389 | 14.158 | 14.224 |
| Total Expenses - EUR | - | - | - | - | 953 | 15.748 | 12.029 | 11.577 | 12.925 | 13.880 |
| Gross Profit/Loss - EUR | - | - | - | - | 354 | 354 | 2.517 | 5.813 | 1.234 | 344 |
| Net Profit/Loss - EUR | - | - | - | - | 341 | 242 | 2.409 | 5.696 | 1.145 | 76 |
| Employees | - | - | - | - | 1 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Endovit Sano S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 23.147 | 27.934 | 23.541 | 19.829 | 15.995 | 12.153 |
| Current Assets | - | - | - | - | 1.323 | 1.885 | 2.931 | 6.981 | 4.810 | 4.504 |
| Inventories | - | - | - | - | 358 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 948 | 930 | 97 | 3.139 | 299 | 197 |
| Cash | - | - | - | - | 16 | 956 | 2.834 | 3.842 | 4.511 | 4.308 |
| Shareholders Funds | - | - | - | - | 383 | 618 | 3.012 | 6.584 | 3.973 | 4.027 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 1.009 | 1.926 | 499 | 916 | 1.291 | 866 |
| Income in Advance | - | - | - | - | 23.079 | 27.276 | 22.960 | 19.310 | 15.540 | 11.764 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Endovit Sano S.r.l.